-
Mashup Score: 6Program Guide – ASCO Meeting Program Guide - 6 hour(s) ago
Mike Wenzel Department of Urology, University Hospital Frankfurt Mike Wenzel , Florestan Koll , Benedikt Hoeh , Clara Humke , Carolin Siech , Nicolai Mader , Daniel Groener , Thomas Steuber , Markus Graefen , Tobias Maurer , Christian Brandts , Severine Banek , Felix Chun , Philipp Mandel Department of Urology, University Hospital Frankfurt, Department of Urology, University Hospital Frankfurt, Goethe University Frankfurt, Department of Nuclear Medicine, University Hospital Frankfurt, Department of Nucle
Source: meetings.asco.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 5Program Guide – ASCO Meeting Program Guide - 6 hour(s) ago
Brigida Anna Maiorano Medical Oncology Department, IRCCS San Raffaele Hospital Brigida Anna Maiorano , Antonio Cigliola , Valentina Tateo , Chiara Mercinelli , Giovanni Luigi Pastorino , Nazli Dizman , Hedyeh Ebrahimi , Sumanta Pal , Shilpa Gupta , Petros Grivas , Ashish Kamat , Philippe Spiess , Neeraj Agarwal , Andrea Necchi Medical Oncology Department, IRCCS San Raffaele Hospital, Medical Oncology Department, IRCCS San Raffaele Hospital; Vita-Salute San Raffaele University, Università Vita e Salute
Source: meetings.asco.orgCategories: General Medicine News, Hem/OncsTweet-
Ab#732 @ASCO #GU25 by @BrigidaMaiorano @AndreaNecchi 👉https://t.co/dzEZK9rzhK👉Efficacy of ICI rechallenge in pts w/ UC #bladdercancer 👉PD-L1 inhibitor followed by PD-1i & >12 mo between ICIs may be better strategy; median OS data below👇@OncoAlert @urotoday @BladdercancerUS https://t.co/SJDGbG1zNr
-
-
Mashup Score: 19Program Guide – ASCO Meeting Program Guide - 6 hour(s) ago
Umang Swami Department of Medicine, Huntsman Cancer Institute at the University of Utah Umang Swami , Yeonjung Jo , Zeynep Irem Ozay , Chadi Hage Chehade , Georges Gebrael , Nicolas Sayegh , Micah Ostrowski , Ethan Anderson , Diya Garg , Ayana Srivastava , Beverly Chigarira , Siqi HU , Vinay Mathew Thomas , Sumati Gupta , Benjamin Maughan , Avirup Guha , Irbaz Riaz , Soumyajit Roy , Neeraj Agarwal Department of Medicine, Huntsman Cancer Institute at the University of Utah, Huntsman Cancer Institute at
Source: meetings.asco.orgCategories: General Medicine News, Hem/OncsTweet-
Ab#104 @ASCO #GU25 by @umangtalking👉https://t.co/aeyp68EfiM👉In pts with mHSPC #prostatecancer in @flatironhealth 👉Glad to report an improved utilization of intensified ADT in 77% of pts since January 2023👇@Huntsman_GU @OncoAlert @urotoday @PCF_Science https://t.co/lAJuPnX13Y
-
-
Mashup Score: 14Program Guide – ASCO Meeting Program Guide - 6 hour(s) ago
Abdenour Nabid , Nathalie Carrier , Andre-Guy Martin , Jean-Paul Bahary , Peter Vavassis , Sylvie Vass , Boris Bahoric , Robert Archambault , Francois Vincent , Redouane Bettahar , Marie Duclos , Luis Souhami Centre Hospitalier Universitaire de Sherbrooke, CHU de Quebec, Université Laval, Centre hospitalier de l’Université de Montréal (CHUM), Hôpital Maisonneuve-Rosemont de Montréal, Centre Intégré Universitaire de Santé et de Services Sociaux du Saguenay-Lac-Saint-Jean, Hôpital Général Juif de Montréal,
Source: meetings.asco.orgCategories: General Medicine News, Hem/OncsTweet-
Ab#310 @ASCO #GU25 by #AbdenourNabid👉https://t.co/B2rj26UXpG👉22 years of f/u on testosterone (T) recovery in pts w/ #prostatecancer s/p RT+ADT👉T recovery to normal level associated w/ significant improvement in OS👇#LuisSouhami @OncoAlert @urotoday @PCF_Science https://t.co/0jkzhwmQnW
-
-
Mashup Score: 16Program Guide – ASCO Meeting Program Guide - 6 hour(s) ago
Giulio Francolini Radiation Oncology Unit, Azienda Ospedaliera Universitaria Careggi, University of Florence Giulio Francolini , Vanessa Di Cataldo , Pietro Garlatti , Saverio Caini , Alessio Bruni , Nicola Simoni , Matteo Augugliaro , Roberto Iacovelli , Luca Tagliaferri , Nicola Battelli , Gianluca Ingrosso , Angelo Porreca , Marco Trovò , Giuseppe Fornarini , Giuseppe Iorio , Alessia Guarneri , Michele Sisani , Lorenzo Antonuzzo , Alfio Di Grazia , Lorenzo Livi Radiation Oncology Unit, Azienda Ospedalie
Source: meetings.asco.orgCategories: General Medicine News, Hem/OncsTweet-
Ab#160 @ASCO #GU25 by @GiulioFrancoli1👉https://t.co/A1JVzqDkrU👉In ph2 PERSIAN trial of ADT+APA +/- SBRT in pts w/ oligo mHSPC #prostatecancer👉Adding SBRT led to⬆️ biochemical response in pts w/ low disease burden👉Trial ongoing👇#LorenzoLivi @OncoAlert @urotoday @PCF_Science https://t.co/UbskqI6avz
-
-
Mashup Score: 17Program Guide – ASCO Meeting Program Guide - 6 hour(s) ago
Nicolas Sayegh , Yeonjung Jo , Umang Swami , Chadi Hage Chehade , Zeynep Irem Ozay , Georges Gebrael , Benjamin Maughan , Melissa Plets , Maha Hussain , Tanya Dorff , Primo Lara Jr., Amir Goldkorn , Seth Lerner , Neeraj Agarwal Huntsman Cancer Institute at the University of Utah, Department of Medicine, Huntsman Cancer Institute at the University of Utah, SWOG Statistic s and Data Management Center, Northwestern University, Feinberg School of Medicine, City of Hope Comprehensive Cancer Center, University
Source: meetings.asco.orgCategories: General Medicine News, Hem/OncsTweet-
Ab#173 @ASCO #GU25 by @nsayeghmd 👉https://t.co/EtqWUtpfNQ👉Secondary analysis of the @SWOG 1216 trial: time to metastasis after prostatectomy was not associated with survival in metachronous mHSPC #prostatecancer👇@Huntsman_GU @OncoAlert @urotoday @PCF_Science https://t.co/NEeeLlQHyj
-
-
Mashup Score: 13Program Guide – ASCO Meeting Program Guide - 6 hour(s) ago
Umang Swami Department of Medicine, Huntsman Cancer Institute at the University of Utah Umang Swami , Yeonjung Jo , Chadi Hage Chehade , Zeynep Irem Ozay , Nicolas Sayegh , Georges Gebrael , Micah Ostrowski , Patrick Campbell , Siqi HU , Gliceida Galarza Fortuna , Vinay Mathew Thomas , Haoran Li , Ryon Graf , Soumyajit Roy , Benjamin Maughan , Avirup Guha , Irbaz Riaz , Emmanuel Antonarakis , Rana McKay , Neeraj Agarwal Department of Medicine, Huntsman Cancer Institute at the University of Utah, Huntsman
Source: meetings.asco.orgCategories: General Medicine News, Hem/OncsTweet-
Ab#95 @ASCO #GU25 by @umangtalking👉https://t.co/1sR9u3eCAw👉In pts w/ mCRPC #prostatecancer in @flatironhealth (n = 14,112)👉43% did not receive a bone-modifying agent👉Need to ⬆️ the use of BMAs in clinical practice👇@Huntsman_GU @OncoAlert @urotoday @PCF_Science https://t.co/pEGwTLo8dg
-
-
Mashup Score: 3Program Guide – ASCO Meeting Program Guide - 6 hour(s) ago
Pedro Barata , Suvina Amin , Alexander Niyazov , Melissa Kirker , Amanda Ribbands , Jake Butcher , Jacob Skilling , Alex Busby , Alastair Hinds , Elena Castro University Hospitals Seidman Cancer Center, Pfizer Inc., Adelphi Real World, Hospital Universitario 12 de Octubre Homologous recombination repair mutations (HRRms) have predictive/prognostic value in metastatic castration-resistant prostate cancer (mCRPC). While therapies are approved for patients (pts) with HRRm mCRPC, HRRm testing data is limited
Source: meetings.asco.orgCategories: General Medicine News, Hem/OncsTweet-
Ab#102 @ASCO #GU25 by @PBarataMD👉https://t.co/FT37nHJ4w6👉In pts w/ mCRPC (n=448) #prostatecancer👉53% received HRRm testing w/ lower testing in pts w/o family history, ⬇️Gleason score & de novo disease👉Need to ⬆️ HRRm testing 👇@Ecastromarcos @OncoAlert @urotoday @PCF_Science https://t.co/tPYZYvEGyQ
-
-
Mashup Score: 10Program Guide – ASCO Meeting Program Guide - 6 hour(s) ago
Arun Azad Department of Medical Oncology, Peter MacCallum Cancer Centre Arun Azad , Marco Badillo , Qiang Dong , Alicia Morgans , Dana Rathkopf , Karie Runcie , Tian Zhang , Geoffrey Gotto , Axel Merseburger , Alex Dos Santos , Sukie Shopeju , Amitabha Bhaumik , Suneel Dinkar Mundle , Sharon McCarthy , Neeraj Ag arwal Department of Medical Oncology, Peter MacCallum Cancer Centre, Hospital Aranda de la Parra, West China Hospital, Sichuan University, Department of Medical Oncology, Dana-Farber Cancer
Source: meetings.asco.orgCategories: General Medicine News, Hem/OncsTweet-
Ab#147 @ASCO #GU25 by @AzadOncology👉https://t.co/zi3ow7N2lD👉In the ph3 LIBERTAS trial in pts w/ mHSPC #prostatecancer (n=350)👉ADT+APA led to undetectable PSA in 70.3% of pts & PSA90 response in 87.7% 👉Trial ongoing👇@Huntsman_GU @OncoAlert @urotoday @PCF_Science https://t.co/iYQJqOIZ6y
-
-
Mashup Score: 11Program Guide – ASCO Meeting Program Guide - 6 hour(s) ago
Alan Bryce , Raymond McDermott , Josep Piulats , M. Reaume , Peter Ostler , Joel Gingerich , Elias Pintus , Srikala Sridhar , Richard Bambury , Urban Emmenegger , Henriette Lindberg , David Morris , Franco Nole , John Staffurth , Wassim Abida , Lisa Caunt , Darrin Despain , Charles Ryan , Karim Fizazi , Simon Chowdhury Mayo Clinic in Arizona, St. Vincent’s University Hospital and University College Dublin, Fundacio Institut D’Investigacio Biomedica de Bellvitge, L’Hospitalet del Llobregat, The Ottawa
Source: meetings.asco.orgCategories: General Medicine News, Hem/OncsTweet-
Ab#155 @ASCO #GU25 by @AlanBryce9👉https://t.co/m8y7F8nksZ👉In ph3 TRITON3 in pts w/ mCRPC #prostatecancer👉Median OS 22.8 mo w/ rucaparib vs. 21.7 w/ docetaxel/ARPI switch (HR 0.99) (70 pts crossed over to rucaparib)👇@scserendipity1 @OncoAlert @urotoday @PCF_Science https://t.co/JiBuoZMWYW
-
Ab#70 @ASCO #GU25 by #MikeWenzel👉https://t.co/t6w6MLff0W👉Real-world comparison of cabazitaxel vs. Lu-177 in pts w/ mCRPC #prostatecancer👉Longer PFS (HR 0.38) & qualitatively better OS rates w/ Lu-177👇#PhilippMande @OncoAlert @urotoday @PCF_Science https://t.co/P0Gu5xD1XA